Their data showed that activated lymphocyte morphology, high levels of IgG and beta-2-microglobulin, and CD38 and/or FMC7 increased expression may raise the risk of an autoimmune disorder in a CLL setting. The gene discussed is CD38; the disease is autoimmune disease.